167 related articles for article (PubMed ID: 29045811)
1. TOP2A induces malignant character of pancreatic cancer through activating β-catenin signaling pathway.
Pei YF; Yin XM; Liu XQ
Biochim Biophys Acta Mol Basis Dis; 2018 Jan; 1864(1):197-207. PubMed ID: 29045811
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of TOP2A in bladder urothelial carcinoma and potential molecular mechanisms.
Zeng S; Liu A; Dai L; Yu X; Zhang Z; Xiong Q; Yang J; Liu F; Xu J; Xue Y; Sun Y; Xu C
BMC Cancer; 2019 Jun; 19(1):604. PubMed ID: 31216997
[TBL] [Abstract][Full Text] [Related]
3. PRRX1-TOP2A interaction is a malignancy-promoting factor in human malignant peripheral nerve sheath tumours.
Takihira S; Yamada D; Osone T; Takao T; Sakaguchi M; Hakozaki M; Itano T; Nakata E; Fujiwara T; Kunisada T; Ozaki T; Takarada T
Br J Cancer; 2024 May; 130(9):1493-1504. PubMed ID: 38448751
[TBL] [Abstract][Full Text] [Related]
4.
Zhao HC; Chen CZ; Tian YZ; Song HQ; Wang XX; Li YJ; He JF; Zhao HL
iScience; 2023 Jun; 26(6):106862. PubMed ID: 37275516
[TBL] [Abstract][Full Text] [Related]
5. Smurf2, an E3 ubiquitin ligase, interacts with PDE4B and attenuates liver fibrosis through miR-132 mediated CTGF inhibition.
Cai Y; Huang G; Ma L; Dong L; Chen S; Shen X; Zhang S; Xue R; Sun D; Zhang S
Biochim Biophys Acta Mol Cell Res; 2018 Feb; 1865(2):297-308. PubMed ID: 29100790
[TBL] [Abstract][Full Text] [Related]
6. Non-Catalytic Roles of the Topoisomerase IIα C-Terminal Domain.
Clarke DJ; Azuma Y
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29149026
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of PAG1/Cbp contributes to adipose-derived mesenchymal stem cells promoted tumor progression and chemoresistance in breast cancer.
Lu Y; Yang Y; Liu Y; Hao Y; Zhang Y; Hu Y; Jiang L; Gong Y; Wu K; Liu Y
Biochem Biophys Res Commun; 2017 Dec; 494(3-4):719-727. PubMed ID: 29079189
[TBL] [Abstract][Full Text] [Related]
8. Integrated expression profiling of potassium channels identifys KCNN4 as a prognostic biomarker of pancreatic cancer.
Jiang S; Zhu L; Yang J; Hu L; Gu J; Xing X; Sun Y; Zhang Z
Biochem Biophys Res Commun; 2017 Dec; 494(1-2):113-119. PubMed ID: 29050937
[TBL] [Abstract][Full Text] [Related]
9. Mutual regulation of MDM4 and TOP2A in cancer cell proliferation.
Liu T; Zhang H; Yi S; Gu L; Zhou M
Mol Oncol; 2019 May; 13(5):1047-1058. PubMed ID: 30672125
[TBL] [Abstract][Full Text] [Related]
10. Proliferation and invasion of colon cancer cells are suppressed by knockdown of TOP2A.
Zhang R; Xu J; Zhao J; Bai JH
J Cell Biochem; 2018 Sep; 119(9):7256-7263. PubMed ID: 29761838
[TBL] [Abstract][Full Text] [Related]
11. Topoisomerases as anticancer targets.
Delgado JL; Hsieh CM; Chan NL; Hiasa H
Biochem J; 2018 Jan; 475(2):373-398. PubMed ID: 29363591
[TBL] [Abstract][Full Text] [Related]
12. KAT2A succinyltransferase activity-mediated 14-3-3ζ upregulation promotes β-catenin stabilization-dependent glycolysis and proliferation of pancreatic carcinoma cells.
Tong Y; Guo D; Yan D; Ma C; Shao F; Wang Y; Luo S; Lin L; Tao J; Jiang Y; Lu Z; Xing D
Cancer Lett; 2020 Jan; 469():1-10. PubMed ID: 31610265
[TBL] [Abstract][Full Text] [Related]
13. Inflammation Promotes Progression of Pancreatic Cancer Through WNT/β-Catenin Pathway-Dependent Manner.
Ren R; Yu J; Zhang Y; Wang SF; Guo X; Shen M; Xu MD; Jiang M; Zhi Q; Chen K; Tao M; Wu MY; Gu DM; Li W
Pancreas; 2019 Sep; 48(8):1003-1014. PubMed ID: 31404031
[TBL] [Abstract][Full Text] [Related]
14. NMIIA promotes tumor growth and metastasis by activating the Wnt/β-catenin signaling pathway and EMT in pancreatic cancer.
Zhou P; Li Y; Li B; Zhang M; Liu Y; Yao Y; Li D
Oncogene; 2019 Jul; 38(27):5500-5515. PubMed ID: 30967633
[TBL] [Abstract][Full Text] [Related]
15. β-catenin-activated autocrine PDGF/Src signaling is a therapeutic target in pancreatic cancer.
Kuo TL; Cheng KH; Shan YS; Chen LT; Hung WC
Theranostics; 2019; 9(2):324-336. PubMed ID: 30809277
[No Abstract] [Full Text] [Related]
16. β-Catenin expression is associated with cell invasiveness in pancreatic cancer.
Nan JN; Kim OR; Lee MA
Korean J Intern Med; 2019 May; 34(3):618-625. PubMed ID: 30360026
[TBL] [Abstract][Full Text] [Related]
17. Multi‑layered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT/β‑catenin signaling activation (Review).
Katoh M
Int J Mol Med; 2018 Aug; 42(2):713-725. PubMed ID: 29786110
[TBL] [Abstract][Full Text] [Related]
18. LncRNA BANCR Promotes Pancreatic Cancer Tumorigenesis via Modulating MiR-195-5p/Wnt/β-Catenin Signaling Pathway.
Wu X; Xia T; Cao M; Zhang P; Shi G; Chen L; Zhang J; Yin J; Wu P; Cai B; Lu Z; Miao Y; Jiang K
Technol Cancer Res Treat; 2019; 18():1533033819887962. PubMed ID: 31769353
[TBL] [Abstract][Full Text] [Related]
19. PRMT1 promotes pancreatic cancer growth and predicts poor prognosis.
Song C; Chen T; He L; Ma N; Li JA; Rong YF; Fang Y; Liu M; Xie D; Lou W
Cell Oncol (Dordr); 2020 Feb; 43(1):51-62. PubMed ID: 31520395
[TBL] [Abstract][Full Text] [Related]
20. IQGAP1 promotes pancreatic cancer progression and epithelial-mesenchymal transition (EMT) through Wnt/β-catenin signaling.
Hu W; Wang Z; Zhang S; Lu X; Wu J; Yu K; Ji A; Lu W; Wang Z; Wu J; Jiang C
Sci Rep; 2019 May; 9(1):7539. PubMed ID: 31101875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
